» Articles » PMID: 17284614

Lnk Negatively Regulates Self-renewal of Hematopoietic Stem Cells by Modifying Thrombopoietin-mediated Signal Transduction

Overview
Specialty Science
Date 2007 Feb 8
PMID 17284614
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

One of the central tasks of stem cell biology is to understand the molecular mechanisms that control self-renewal in stem cells. Several cytokines are implicated as crucial regulators of hematopoietic stem cells (HSCs), but little is known about intracellular signaling for HSC self-renewal. To address this issue, we attempted to clarify how self-renewal potential is enhanced in HSCs without the adaptor molecule Lnk, as in Lnk-deficient mice HSCs are expanded in number >10-fold because of their increased self-renewal potential. We show that Lnk negatively regulates self-renewal of HSCs by modifying thrombopoietin (TPO)-mediated signal transduction. Single-cell cultures showed that Lnk-deficient HSCs are hypersensitive to TPO. Competitive repopulation revealed that long-term repopulating activity increases in Lnk-deficient HSCs, but not in WT HSCs, when these cells are cultured in the presence of TPO with or without stem cell factor. Single-cell transplantation of each of the paired daughter cells indicated that a combination of stem cell factor and TPO efficiently induces symmetrical self-renewal division in Lnk-deficient HSCs but not in WT HSCs. Newly developed single-cell immunostaining demonstrated significant enhancement of both p38 MAPK inactivation and STAT5 and Akt activation in Lnk-deficient HSCs after stimulation with TPO. Our results suggest that a balance in positive and negative signals downstream from the TPO signal plays a role in the regulation of the probability of self-renewal in HSCs. In general, likewise, the fate of stem cells may be determined by combinational changes in multiple signal transduction pathways.

Citing Articles

LNK/SH2B3 Loss Exacerbates the Development of Myeloproliferative Neoplasms in CBL-deficient Mice.

Chen Y, Gong S, Tang J, Wang X, Gao Y, Yang H Stem Cell Rev Rep. 2024; 21(2):509-519.

PMID: 39560864 DOI: 10.1007/s12015-024-10825-0.


PTIP epigenetically regulates DNA damage-induced cell cycle arrest by upregulating PRDM1.

Nakata Y, Nagasawa S, Sera Y, Yamasaki N, Kanai A, Kobatake K Sci Rep. 2024; 14(1):17987.

PMID: 39097652 PMC: 11297997. DOI: 10.1038/s41598-024-68295-w.


Control of germinal center B cell survival and IgE production by an adaptor molecule containing PH and SH2 domains, Aps/Sh2b2.

Iseki M, Hidano S, Kudo F, Takaki S Sci Rep. 2024; 14(1):17767.

PMID: 39090233 PMC: 11294469. DOI: 10.1038/s41598-024-68739-3.


Chemically defined cytokine-free expansion of human haematopoietic stem cells.

Sakurai M, Ishitsuka K, Ito R, Wilkinson A, Kimura T, Mizutani E Nature. 2023; 615(7950):127-133.

PMID: 36813966 DOI: 10.1038/s41586-023-05739-9.


Resolving the hematopoietic stem cell state by linking functional and molecular assays.

Jassinskaja M, Gonka M, Kent D Blood. 2023; 142(6):543-552.

PMID: 36735913 PMC: 10644060. DOI: 10.1182/blood.2022017864.


References
1.
Ema H, Sudo K, Seita J, Matsubara A, Morita Y, Osawa M . Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell. 2005; 8(6):907-14. DOI: 10.1016/j.devcel.2005.03.019. View

2.
Tong W, Zhang J, Lodish H . Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood. 2005; 105(12):4604-12. PMC: 1894992. DOI: 10.1182/blood-2004-10-4093. View

3.
Krutzik P, Hale M, Nolan G . Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol. 2005; 175(4):2366-73. DOI: 10.4049/jimmunol.175.4.2366. View

4.
Takizawa H, Kubo-Akashi C, Nobuhisa I, Kwon S, Iseki M, Taga T . Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood. 2005; 107(7):2968-75. DOI: 10.1182/blood-2005-05-2138. View

5.
Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K . Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006; 12(4):446-51. DOI: 10.1038/nm1388. View